Bifogade filer
PDF
Beskrivning
| Land | Danmark |
|---|---|
| Lista | Spotlight DK |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, SWITZERLAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, RUSSIA, BELARUS OR ANY OTHER JURISDICTION WHERE THIS PRESS RELEASE IS DISTRIBUTABLE WOULD BE ILLEGAL OR REQUIRE ADDITIONAL ACTIONS THAN SUCH ACTIONS RESULTING FROM DANISH LAW. SEE THE "IMPORTANT INFORMATION" SECTION AT THE END OF THIS PRESS RELEASE.
The Board of Directors of Curasight A/S ("Curasight" or the "Company" - TICKER: CURAS), has today, based on the authorization granted by the extraordinary general meeting on 23 April 2025, resolved on a directed issue of 977,768 shares to guarantors who have entered into guarantee commitments in the rights issue of shares announced on 4 April 2025 (the "Rights Issue") and who have chosen to receive guarantee compensation in the form of newly issued shares (the "Directed Issue"). The subscription price in the Directed Issue amounts to DKK 1.98 per share, which corresponds to the subscription price in the Rights Issue. Payment is made by offsetting the guarantor's claim for guarantee compensation.
The Directed Issue
In connection with the announcement of the Rights Issue, it was communicated that the Rights Issue was covered by guarantee commitments amounting to a total of approximately DKK 19.3 million. In accordance with the guarantee agreements, guarantee commitments were entitled to a guarantee compensation corresponding to 13 per cent of the guaranteed amount in cash or 22 per cent of the guaranteed amount in newly issued shares in the Company.
The guarantors who have not opted to receive their guarantee compensation in the form of new shares will instead receive cash compensation for their respective guarantee commitments. The cash portion of the guarantee compensation amounts to approximately DKK 1.36 million.
The reason for the deviation from the shareholders' preferential rights in the Directed Issue is to fulfill the Company's contractual obligation towards the guarantors. The Board of Directors believes that it is to the advantage of the Company's financial position to take advantage of the opportunity to pay the guarantee compensation in the form of newly issued shares instead of cash payment.
Resolutions on the Directed Issue have been made based on the authorization from the Extraordinary General Meeting held on 23 April 2025. The subscription price for shares issued through the Directed Issue has, in accordance with the guarantee agreements, been set at DKK 1.98 per share. The subscription price has been determined through arm's length negotiations between the Company and the Guarantors. The Board of Directors has made the assessment that the terms and conditions have thus been determined in such a way that market conditions have been ensured and that they reflect the current market situation. Payment in the Directed Issue will be made by set-off of the Guarantors' respective claims for guarantee compensation against the Company.
Total increase in the number of shares and share capital
Through the Directed Issue, the share capital increases by a total of DKK 48,888.40, from DKK 2,244,312.10 to DKK 2,293,200.50, through a new issue of a total of 977,768 shares, which means that the total number of shares increases from 44,886,242 to 45,864,010 shares, corresponding to a total dilution of approximately 2.1 percent of the share capital and voting rights.
Advisors
Sedermera Corporate Finance AB acts as Sole Global Coordinator and bookrunner in connection with the Rights Issue. DLA Piper is the Company's legal advisor. Danske Bank A/S is the settlement agent.